CORESTEMCHEMON Inc. is a bio-pharmaceutical company based in Seongnam-si, South Korea, founded in 2003. It develops and produces stem cell therapies for incurable diseases, including NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for amyotrophic lateral sclerosis (ALS). The company is also developing therapies for systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA). It has a strategic partnership with ATG Lifetech to deliver precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures. The company was formerly known as Corestem, Inc.